Skip to main navigation Skip to search Skip to main content

Barrett's esophagus: Treatments of adenocarcinomas II

  • William S. Twaddell
  • , Peter C. Wu
  • , Roy J.J. Verhage
  • , Marcus Feith
  • , David H. Ilson
  • , Christoph P. Schuhmacher
  • , James D. Luketich
  • , Björn Brücher
  • , Daniel Vallböhmer
  • , Wayne L. Hofstetter
  • , Mark Jonathan Krasna
  • , Daniela Kandioler
  • , Paul M. Schneider
  • , Bas P.L. Wijnhoven
  • , Stephen J. Sontag
  • University of Maryland Hospital
  • Veterans Affairs Puget Sound Health Care System
  • University Medical Center Utrecht
  • Technical University of Munich
  • Weill Cornell Medical College
  • University of Pittsburgh Medical Center
  • University of Tübingen
  • University of Cologne
  • University of Texas Health Science Center at Houston
  • St. Joseph Medical Center
  • Medical University of Vienna
  • University Hospital Zurich
  • Erasmus University Medical Center
  • Edward Hines VA Medical Center

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.

Original languageEnglish
Pages (from-to)265-291
Number of pages27
JournalAnnals of the New York Academy of Sciences
Volume1232
Issue number1
DOIs
StatePublished - Sep 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 5-FU
  • AEG
  • Adenocarcinoma
  • Adenovirus vector
  • Barrett's esophagus
  • Chemoradiation
  • Chemoradiotherapy
  • Cisplatin
  • EGFR
  • Esophageal cancer
  • FDG PET scan
  • FOLFOX
  • Gamma probe
  • Gefitinib
  • HER2
  • High risk patients
  • Integrated PET/CT scan
  • Lymphadenectomy
  • Minimally invasive esophagectomy
  • Molecular markers
  • Multimodality therapy
  • Neoadjuvant chemotherapy
  • P53
  • PET tracer
  • Prognosis
  • R0 resection
  • Radiotherapy
  • Residual disease
  • Robot assisted thoracolaparoscopic esophagectomy
  • Robotic surgery
  • Sentinel lymph nodes
  • Sentinel node
  • Siewert 's classification
  • Submucosal invasion
  • Two-stade esophagectomy

Fingerprint

Dive into the research topics of 'Barrett's esophagus: Treatments of adenocarcinomas II'. Together they form a unique fingerprint.

Cite this